Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 383

1.

Cost effectiveness of a smoking cessation program in patients admitted for coronary heart disease.

Quist-Paulsen P, Lydersen S, Bakke PS, Gallefoss F.

Eur J Cardiovasc Prev Rehabil. 2006 Apr;13(2):274-80.

PMID:
16575284
[PubMed - indexed for MEDLINE]
2.

Cost-effectiveness of a smoking cessation program after myocardial infarction.

Krumholz HM, Cohen BJ, Tsevat J, Pasternak RC, Weinstein MC.

J Am Coll Cardiol. 1993 Nov 15;22(6):1697-702.

PMID:
8227841
[PubMed - indexed for MEDLINE]
Free Article
3.

Encouraging smokers to quit: the cost effectiveness of reimbursing the costs of smoking cessation treatment.

Kaper J, Wagena EJ, van Schayck CP, Severens JL.

Pharmacoeconomics. 2006;24(5):453-64.

PMID:
16706571
[PubMed - indexed for MEDLINE]
4.

Cost-effectiveness of HMG coenzyme reductase inhibitors; whom to treat?

van Hout BA, Simoons ML.

Eur Heart J. 2001 May;22(9):751-61.

PMID:
11350107
[PubMed - indexed for MEDLINE]
Free Article
5.

Predictors of smoking cessation in patients admitted for acute coronary heart disease.

Quist-Paulsen P, Bakke PS, Gallefoss F.

Eur J Cardiovasc Prev Rehabil. 2005 Oct;12(5):472-7.

PMID:
16210934
[PubMed - indexed for MEDLINE]
6.

Incremental benefit and cost-effectiveness of high-dose statin therapy in high-risk patients with coronary artery disease.

Chan PS, Nallamothu BK, Gurm HS, Hayward RA, Vijan S.

Circulation. 2007 May 8;115(18):2398-409. Epub 2007 Apr 23.

PMID:
17452609
[PubMed - indexed for MEDLINE]
Free Article
7.

'Cut down to quit' with nicotine replacement therapies in smoking cessation: a systematic review of effectiveness and economic analysis.

Wang D, Connock M, Barton P, Fry-Smith A, Aveyard P, Moore D.

Health Technol Assess. 2008 Feb;12(2):iii-iv, ix-xi, 1-135. Review.

PMID:
18093448
[PubMed - indexed for MEDLINE]
Free Article
8.

Design of a cost-effectiveness study within a randomized trial: the LIPID Trial for Secondary Prevention of IHD. Long-term Intervention with Pravastatin in Ischemic Heart disease.

Glasziou PP, Simes RJ, Hall J, Donaldson C.

Control Clin Trials. 1997 Oct;18(5):464-76.

PMID:
9315428
[PubMed - indexed for MEDLINE]
9.

Impact and cost-effectiveness of smoking interventions.

Tsevat J.

Am J Med. 1992 Jul 15;93(1A):43S-47S. Review.

PMID:
1497003
[PubMed - indexed for MEDLINE]
10.

Costs and effects of secondary prevention with perindopril in stable coronary heart disease in Poland: an analysis of the EUROPA study including 1251 Polish patients.

Redekop WK, Orlewska E, Maciejewski P, Rutten FF, Niessen LW.

Pharmacoeconomics. 2008;26(10):861-77.

PMID:
18793033
[PubMed - indexed for MEDLINE]
11.

Cost-effectiveness analysis of a family physician delivered smoking cessation program.

Buck DJ, Richmond RL, Mendelsohn CP.

Prev Med. 2000 Dec;31(6):641-8.

PMID:
11133329
[PubMed - indexed for MEDLINE]
12.

Cost effectiveness of lopinavir/ritonavir compared with atazanavir in antiretroviral-naive patients: modelling the combined effects of HIV and heart disease.

Simpson KN, Luo MP, Chumney EC, King MS, Brun S.

Clin Drug Investig. 2007;27(1):67-74.

PMID:
17177581
[PubMed - indexed for MEDLINE]
13.

Cost-effective primary care-based strategies to improve smoking cessation: more value for money.

Salize HJ, Merkel S, Reinhard I, Twardella D, Mann K, Brenner H.

Arch Intern Med. 2009 Feb 9;169(3):230-5; discussion 235-6. doi: 10.1001/archinternmed.2008.556.

PMID:
19204212
[PubMed - indexed for MEDLINE]
14.
15.

How can we best prolong life? Benefits of coronary risk factor reduction in non-diabetic and diabetic subjects.

Yudkin JS.

BMJ. 1993 May 15;306(6888):1313-8. Erratum in: BMJ 1993 Jul;307(6896):116. BMJ 1993 Jun 26;306(6894):1739.

PMID:
8518573
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Cost-effectiveness of statins in the primary prevention of cardiovascular disease: a systematic review and economic analysis for Belgium.

Neyt M, De Laet C, Van Brabandt H, Franco O, Ramaekers D.

Acta Cardiol. 2009 Feb;64(1):1-10. Review.

PMID:
19317290
[PubMed - indexed for MEDLINE]
17.

The cost-effectiveness of fluvastatin in Hungary following successful percutaneous coronary intervention.

Scuffham PA, Kósa J.

Cardiovasc Drugs Ther. 2006 Aug;20(4):309-17.

PMID:
16779529
[PubMed - indexed for MEDLINE]
19.

The cost-effectiveness of an early interventional strategy in non-ST-elevation acute coronary syndrome based on the RITA 3 trial.

Henriksson M, Epstein DM, Palmer SJ, Sculpher MJ, Clayton TC, Pocock SJ, Henderson RA, Buxton MJ, Fox KA.

Heart. 2008 Jun;94(6):717-23. Epub 2007 Nov 21.

PMID:
18032459
[PubMed - indexed for MEDLINE]
20.

The cost-effectiveness of the English smoking treatment services: evidence from practice.

Godfrey C, Parrott S, Coleman T, Pound E.

Addiction. 2005 Apr;100 Suppl 2:70-83.

PMID:
15844290
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk